Senores Pharmaceuticals Plans ₹43 Crore Capacity Expansion Across US and India, Adds Prefilled Syringe Line

Senores Pharmaceuticals will expand capacity at its US subsidiary Havix from 1.2 billion to 2 billion units a year and at Apnar Pharma in India from 0.5 billion to 1.2 billion units, and add a 2.7 million-unit prefilled syringe line at Ratnatris, for an estimated ₹43 crore by March 2027.